| Financial Year |
March 31 2023 |
| Monetary Funds |
1,694,491,473.30 |
| Held-for-trading Financial Assets |
583,831,172.37 |
| Notes Receivable |
439,941,379.36 |
| Accounts Receivable |
1,657,959,636.35 |
| Advances to Suppliers |
23,994,388.66 |
| Other Receivables |
308,406,014.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,069,577,923.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
144,470,527.67 |
| Total Current Assets |
7,311,464,355.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
29,000,000.00 |
| Long-term Equity Investment |
369,273,431.93 |
| Investment Properties |
27,218,947.79 |
| Fixed Assetes |
1,349,944,353.17 |
| Under-construction Projects |
194,177,996.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
572,911,023.90 |
| R&D expenses |
67,098,058.07 |
| Goodwill |
1,695,237,544.66 |
| Long-Term Deferred and Prepaid Expenses |
21,369,092.18 |
| Deferred Income Tax Assets |
243,526,883.94 |
| Other Non-Current Assets |
166,266,501.77 |
| Sub-Total of Non-Current Assets |
4,847,522,211.12 |
| Total Assets |
12,158,986,566.78 |
| Short-Term Loans |
1,473,644,048.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,431,091,592.51 |
| Accounts Payable |
1,643,013,397.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
126,763,355.44 |
| Taxes Payable |
36,591,162.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
51,467,544.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,296,363.62 |
| Other Current Liabilities |
1,031,441,048.43 |
| Sub-Total of Current Liabilities |
5,967,911,829.89 |
| Long-term Loans |
178,201,140.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,865,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
177,972,314.28 |
| Deferred Income Tax Liabilities |
27,233,066.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
523,346,894.93 |
| Total Liabilities |
6,491,258,724.82 |
| Paid-In Capital(Or Share Stock) |
3,243,258,144.00 |
| Capital Surplus |
1,362,200,209.90 |
| Surplus Reserve |
81,647,706.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
820,543,357.60 |
| Minority Stockholder's Interest |
116,341,364.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,551,386,477.15 |
| Owner's Equity（Stockholder's Equity） |
5,667,727,841.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,158,986,566.78 |
